300
Participants
Start Date
July 16, 2015
Primary Completion Date
March 7, 2017
Study Completion Date
February 13, 2020
Clostridium difficile Vaccine
0.5 mL intramuscular injection.
Placebo
0.5 mL intramuscular injection
Wake Research Associates, LLC, Raleigh
PMG Research of Wilmington, LLC, Wilmington
Avail Clinical Research, LLC, DeLand
QPS-MRA, LLC (Broward Research Group), Hollywood
QPS-MRA, LLC (Miami Research Associates), South Miami
Cincinnati Childrens Hospital Medical Center, Cincinnati
Cincinnati Childrens Hospital Medical Center, Cincinnati
Vince & Associates Clinical Research, Inc., Overland Park
Vince & Associates Clinical Research, Inc, Overland Park
Meridian Clinical Research, LLC, Omaha
Texas Center For Drug Development, Inc., Houston
Clinical Trials of Texas, Inc., San Antonio
Benchmark Research, Austin
J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Clinical Research Center of Nevada LLC, Las Vegas
East-West Medical Research Institute, Honolulu
Lead Sponsor
Pfizer
INDUSTRY